BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Refeyn - ECPv6.16.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Refeyn X-ORIGINAL-URL:https://refeyn.com X-WR-CALDESC:Events for Refeyn REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/Paris BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20261025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20270328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20271031T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Berlin BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20261025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0200 TZNAME:CEST DTSTART:20270328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0200 TZOFFSETTO:+0100 TZNAME:CET DTSTART:20271031T010000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Denver BEGIN:DAYLIGHT TZOFFSETFROM:-0700 TZOFFSETTO:-0600 TZNAME:MDT DTSTART:20250309T090000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0600 TZOFFSETTO:-0700 TZNAME:MST DTSTART:20251102T080000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0700 TZOFFSETTO:-0600 TZNAME:MDT DTSTART:20260308T090000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0600 TZOFFSETTO:-0700 TZNAME:MST DTSTART:20261101T080000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0700 TZOFFSETTO:-0600 TZNAME:MDT DTSTART:20270314T090000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0600 TZOFFSETTO:-0700 TZNAME:MST DTSTART:20271107T080000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Europe/Paris:20260520T160000 DTEND;TZID=Europe/Paris:20260520T170000 DTSTAMP:20260518T120154 CREATED:20260508T134729Z LAST-MODIFIED:20260508T141043Z UID:10000030-1779292800-1779296400@refeyn.com SUMMARY:Adoption of New Technologies in CGT Manufacturing: Challenges and Drivers DESCRIPTION:The MyMass™ mass photometer enables researchers to quickly verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR and other demanding experimental workflows. \n \n \n \n \n \n \n \n \n Compact\, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR\, and other costly experiments.Read this announcement in other languages (including Chinese\, French\, German\, Italian\, Japanese\, Korean\, and Spanish). \n \n \n \n \n \n \n \n Oxford\, UK – 18 March 2026 – Refeyn\, developer of pioneering mass photometry technology\, announces the launch of MyMass™ mass photometer (MyMassMP)\, a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?  Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered\, but depend on high-quality samples. Structural and biophysical workflows\, such as cryo-EM\, native mass spectrometry (MS)\, bio-layer interferometry (BLI)\, and surface plasmon resonance (SPR)\, are time-consuming and costly\, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast\, accurate assessment of purity\, homogeneity\, and oligomerization state in solution before committing to resource-intensive experiments.   Built on the same proven technology as Refeyn’s TwoMP mass photometer\, which is already trusted across leading structural biology and biotherapeutics labs worldwide\, MyMassMP brings this quality check capability into a simpler\, self-contained benchtop instrument. Featuring an integrated display and computer for onboard data analysis\, and dedicated consumables\, it offers an intuitive workflow from sample to result.   \n \n \n \n “Structural biology and AI-driven drug discovery are moving fast\, but they’re only as good as the samples that drive them. MyMassMP directly addresses that challenge and marks a significant step forward for Refeyn\, putting the power of mass photometry within reach of more researchers than ever before\,”  \n \n \n \n – Gerry Mackay\, Refeyn CEO \n \n \n \n “In recent years\, our users have consistently shown us how valuable mass photometry is for quickly assessing sample quality before committing to more complex experiments. With MyMassMP\, we’re making this capability even more accessible – empowering researchers to confidently answer a simple but critical question: Are my samples ready?”  \n \n \n \n – Fiona Coats\, Chief Product and Marketing Officer at Refeyn \n \n \n \n MyMassMP is available now. Learn more at: refeyn.com/mymass   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Refeyn Refeyn (www.refeyn.com) specializes in the development\, production\, and distribution of mass photometry for industry and academia. Enabling accurate mass measurement of single molecules in their native state\, and without labels\, Refeyn’s products deliver crucial analytics faster and use less sample than conventional methods. The company’s vision is to accelerate discovery through innovation\, empowering the latest scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.   Contact: Catie Lichten – Scientific Communications Manager catie.lichten@refeyn.com   URL:https://refeyn.com/events-calendar/adoption-of-new-technologies-in-cgt-manufacturing-challenges-and-drivers LOCATION:Virtual Event\, United Kingdom CATEGORIES:Webinar ATTACH;FMTTYPE=image/png:https://refeyn.com/wp-content/uploads/2026/05/Gen-Sept-Social-ad-1080-x-1080-px.png GEO:55.378051;-3.435973 END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260610 DTEND;VALUE=DATE:20260613 DTSTAMP:20260518T120154 CREATED:20251218T113949Z LAST-MODIFIED:20260225T153538Z UID:10000016-1781049600-1781308799@refeyn.com SUMMARY:Applied Biophysics Forum in Drug Delivery DESCRIPTION:The MyMass™ mass photometer enables researchers to quickly verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR and other demanding experimental workflows. \n \n \n \n \n \n \n \n \n Compact\, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR\, and other costly experiments.Read this announcement in other languages (including Chinese\, French\, German\, Italian\, Japanese\, Korean\, and Spanish). \n \n \n \n \n \n \n \n Oxford\, UK – 18 March 2026 – Refeyn\, developer of pioneering mass photometry technology\, announces the launch of MyMass™ mass photometer (MyMassMP)\, a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?  Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered\, but depend on high-quality samples. Structural and biophysical workflows\, such as cryo-EM\, native mass spectrometry (MS)\, bio-layer interferometry (BLI)\, and surface plasmon resonance (SPR)\, are time-consuming and costly\, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast\, accurate assessment of purity\, homogeneity\, and oligomerization state in solution before committing to resource-intensive experiments.   Built on the same proven technology as Refeyn’s TwoMP mass photometer\, which is already trusted across leading structural biology and biotherapeutics labs worldwide\, MyMassMP brings this quality check capability into a simpler\, self-contained benchtop instrument. Featuring an integrated display and computer for onboard data analysis\, and dedicated consumables\, it offers an intuitive workflow from sample to result.   \n \n \n \n “Structural biology and AI-driven drug discovery are moving fast\, but they’re only as good as the samples that drive them. MyMassMP directly addresses that challenge and marks a significant step forward for Refeyn\, putting the power of mass photometry within reach of more researchers than ever before\,”  \n \n \n \n – Gerry Mackay\, Refeyn CEO \n \n \n \n “In recent years\, our users have consistently shown us how valuable mass photometry is for quickly assessing sample quality before committing to more complex experiments. With MyMassMP\, we’re making this capability even more accessible – empowering researchers to confidently answer a simple but critical question: Are my samples ready?”  \n \n \n \n – Fiona Coats\, Chief Product and Marketing Officer at Refeyn \n \n \n \n MyMassMP is available now. Learn more at: refeyn.com/mymass   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Refeyn Refeyn (www.refeyn.com) specializes in the development\, production\, and distribution of mass photometry for industry and academia. Enabling accurate mass measurement of single molecules in their native state\, and without labels\, Refeyn’s products deliver crucial analytics faster and use less sample than conventional methods. The company’s vision is to accelerate discovery through innovation\, empowering the latest scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.   Contact: Catie Lichten – Scientific Communications Manager catie.lichten@refeyn.com   URL:https://refeyn.com/events-calendar/applied-biophysics-forum-in-drug-delivery LOCATION:Collège Doctoral Européen (CDE)\, 46 Bd de la Victoire\, Strasbourg\, 67000\, France CATEGORIES:Conference ATTACH;FMTTYPE=image/avif:https://refeyn.com/wp-content/uploads/2025/12/Applied-Biophysics-Forum.avif GEO:47.5645067;7.6021396 X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Collège Doctoral Européen (CDE) 46 Bd de la Victoire Strasbourg 67000 France;X-APPLE-RADIUS=500;X-TITLE=46 Bd de la Victoire:geo:7.6021396,47.5645067 END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260803 DTEND;VALUE=DATE:20260807 DTSTAMP:20260518T120155 CREATED:20251203T213808Z LAST-MODIFIED:20251203T215137Z UID:10000008-1785715200-1786060799@refeyn.com SUMMARY:Colorado Protein Stability DESCRIPTION:The MyMass™ mass photometer enables researchers to quickly verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR and other demanding experimental workflows. \n \n \n \n \n \n \n \n \n Compact\, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR\, and other costly experiments.Read this announcement in other languages (including Chinese\, French\, German\, Italian\, Japanese\, Korean\, and Spanish). \n \n \n \n \n \n \n \n Oxford\, UK – 18 March 2026 – Refeyn\, developer of pioneering mass photometry technology\, announces the launch of MyMass™ mass photometer (MyMassMP)\, a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?  Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered\, but depend on high-quality samples. Structural and biophysical workflows\, such as cryo-EM\, native mass spectrometry (MS)\, bio-layer interferometry (BLI)\, and surface plasmon resonance (SPR)\, are time-consuming and costly\, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast\, accurate assessment of purity\, homogeneity\, and oligomerization state in solution before committing to resource-intensive experiments.   Built on the same proven technology as Refeyn’s TwoMP mass photometer\, which is already trusted across leading structural biology and biotherapeutics labs worldwide\, MyMassMP brings this quality check capability into a simpler\, self-contained benchtop instrument. Featuring an integrated display and computer for onboard data analysis\, and dedicated consumables\, it offers an intuitive workflow from sample to result.   \n \n \n \n “Structural biology and AI-driven drug discovery are moving fast\, but they’re only as good as the samples that drive them. MyMassMP directly addresses that challenge and marks a significant step forward for Refeyn\, putting the power of mass photometry within reach of more researchers than ever before\,”  \n \n \n \n – Gerry Mackay\, Refeyn CEO \n \n \n \n “In recent years\, our users have consistently shown us how valuable mass photometry is for quickly assessing sample quality before committing to more complex experiments. With MyMassMP\, we’re making this capability even more accessible – empowering researchers to confidently answer a simple but critical question: Are my samples ready?”  \n \n \n \n – Fiona Coats\, Chief Product and Marketing Officer at Refeyn \n \n \n \n MyMassMP is available now. Learn more at: refeyn.com/mymass   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Refeyn Refeyn (www.refeyn.com) specializes in the development\, production\, and distribution of mass photometry for industry and academia. Enabling accurate mass measurement of single molecules in their native state\, and without labels\, Refeyn’s products deliver crucial analytics faster and use less sample than conventional methods. The company’s vision is to accelerate discovery through innovation\, empowering the latest scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.   Contact: Catie Lichten – Scientific Communications Manager catie.lichten@refeyn.com   URL:https://refeyn.com/events-calendar/colorado-protein-stability LOCATION:Beaver Run Resort and Conference Center\, 620 Village Road\, Breckenridge\, CO\, 80424\, United States CATEGORIES:Conference GEO:39.4738392;-106.0506084 X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Beaver Run Resort and Conference Center 620 Village Road Breckenridge CO 80424 United States;X-APPLE-RADIUS=500;X-TITLE=620 Village Road:geo:-106.0506084,39.4738392 END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260810 DTEND;VALUE=DATE:20260814 DTSTAMP:20260518T120155 CREATED:20251203T214223Z LAST-MODIFIED:20251203T215026Z UID:10000009-1786320000-1786665599@refeyn.com SUMMARY:The 18th Annual Bioprocessing Summit (BPS) DESCRIPTION:The MyMass™ mass photometer enables researchers to quickly verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR and other demanding experimental workflows. \n \n \n \n \n \n \n \n \n Compact\, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR\, and other costly experiments.Read this announcement in other languages (including Chinese\, French\, German\, Italian\, Japanese\, Korean\, and Spanish). \n \n \n \n \n \n \n \n Oxford\, UK – 18 March 2026 – Refeyn\, developer of pioneering mass photometry technology\, announces the launch of MyMass™ mass photometer (MyMassMP)\, a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?  Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered\, but depend on high-quality samples. Structural and biophysical workflows\, such as cryo-EM\, native mass spectrometry (MS)\, bio-layer interferometry (BLI)\, and surface plasmon resonance (SPR)\, are time-consuming and costly\, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast\, accurate assessment of purity\, homogeneity\, and oligomerization state in solution before committing to resource-intensive experiments.   Built on the same proven technology as Refeyn’s TwoMP mass photometer\, which is already trusted across leading structural biology and biotherapeutics labs worldwide\, MyMassMP brings this quality check capability into a simpler\, self-contained benchtop instrument. Featuring an integrated display and computer for onboard data analysis\, and dedicated consumables\, it offers an intuitive workflow from sample to result.   \n \n \n \n “Structural biology and AI-driven drug discovery are moving fast\, but they’re only as good as the samples that drive them. MyMassMP directly addresses that challenge and marks a significant step forward for Refeyn\, putting the power of mass photometry within reach of more researchers than ever before\,”  \n \n \n \n – Gerry Mackay\, Refeyn CEO \n \n \n \n “In recent years\, our users have consistently shown us how valuable mass photometry is for quickly assessing sample quality before committing to more complex experiments. With MyMassMP\, we’re making this capability even more accessible – empowering researchers to confidently answer a simple but critical question: Are my samples ready?”  \n \n \n \n – Fiona Coats\, Chief Product and Marketing Officer at Refeyn \n \n \n \n MyMassMP is available now. Learn more at: refeyn.com/mymass   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Refeyn Refeyn (www.refeyn.com) specializes in the development\, production\, and distribution of mass photometry for industry and academia. Enabling accurate mass measurement of single molecules in their native state\, and without labels\, Refeyn’s products deliver crucial analytics faster and use less sample than conventional methods. The company’s vision is to accelerate discovery through innovation\, empowering the latest scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.   Contact: Catie Lichten – Scientific Communications Manager catie.lichten@refeyn.com   URL:https://refeyn.com/events-calendar/the-18th-annual-bioprocessing-summit-bps LOCATION:Omni Boston Hotel\, 450 Summer St\, Boston\, MA\, 02210\, United States CATEGORIES:Conference GEO:42.3468772;-71.0426731 X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Omni Boston Hotel 450 Summer St Boston MA 02210 United States;X-APPLE-RADIUS=500;X-TITLE=450 Summer St:geo:-71.0426731,42.3468772 END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260913 DTEND;VALUE=DATE:20260916 DTSTAMP:20260518T120155 CREATED:20251203T214637Z LAST-MODIFIED:20251215T201615Z UID:10000010-1789257600-1789516799@refeyn.com SUMMARY:Festival of Biologics - EU (Basel) DESCRIPTION:The MyMass™ mass photometer enables researchers to quickly verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR and other demanding experimental workflows. \n \n \n \n \n \n \n \n \n Compact\, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM\, native MS\, BLI\, SPR\, and other costly experiments.Read this announcement in other languages (including Chinese\, French\, German\, Italian\, Japanese\, Korean\, and Spanish). \n \n \n \n \n \n \n \n Oxford\, UK – 18 March 2026 – Refeyn\, developer of pioneering mass photometry technology\, announces the launch of MyMass™ mass photometer (MyMassMP)\, a compact instrument designed to answer a critical research question: Is the sample good enough for further analysis?  Structure-based drug design and AI-driven therapeutic development are transforming how new medicines are discovered\, but depend on high-quality samples. Structural and biophysical workflows\, such as cryo-EM\, native mass spectrometry (MS)\, bio-layer interferometry (BLI)\, and surface plasmon resonance (SPR)\, are time-consuming and costly\, and poor sample quality remains one of the main reasons they fail. MyMassMP gives researchers a fast\, accurate assessment of purity\, homogeneity\, and oligomerization state in solution before committing to resource-intensive experiments.   Built on the same proven technology as Refeyn’s TwoMP mass photometer\, which is already trusted across leading structural biology and biotherapeutics labs worldwide\, MyMassMP brings this quality check capability into a simpler\, self-contained benchtop instrument. Featuring an integrated display and computer for onboard data analysis\, and dedicated consumables\, it offers an intuitive workflow from sample to result.   \n \n \n \n “Structural biology and AI-driven drug discovery are moving fast\, but they’re only as good as the samples that drive them. MyMassMP directly addresses that challenge and marks a significant step forward for Refeyn\, putting the power of mass photometry within reach of more researchers than ever before\,”  \n \n \n \n – Gerry Mackay\, Refeyn CEO \n \n \n \n “In recent years\, our users have consistently shown us how valuable mass photometry is for quickly assessing sample quality before committing to more complex experiments. With MyMassMP\, we’re making this capability even more accessible – empowering researchers to confidently answer a simple but critical question: Are my samples ready?”  \n \n \n \n – Fiona Coats\, Chief Product and Marketing Officer at Refeyn \n \n \n \n MyMassMP is available now. Learn more at: refeyn.com/mymass   \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Refeyn Refeyn (www.refeyn.com) specializes in the development\, production\, and distribution of mass photometry for industry and academia. Enabling accurate mass measurement of single molecules in their native state\, and without labels\, Refeyn’s products deliver crucial analytics faster and use less sample than conventional methods. The company’s vision is to accelerate discovery through innovation\, empowering the latest scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.   Contact: Catie Lichten – Scientific Communications Manager catie.lichten@refeyn.com   URL:https://refeyn.com/events-calendar/festival-of-biologics-eu-basel LOCATION:Collège Doctoral Européen (CDE)\, 46 Bd de la Victoire\, Strasbourg\, 67000\, France CATEGORIES:Conference ATTACH;FMTTYPE=image/jpeg:https://refeyn.com/wp-content/uploads/2025/12/Festival-of-Biologics.jpg GEO:47.5645067;7.6021396 X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Collège Doctoral Européen (CDE) 46 Bd de la Victoire Strasbourg 67000 France;X-APPLE-RADIUS=500;X-TITLE=46 Bd de la Victoire:geo:7.6021396,47.5645067 END:VEVENT END:VCALENDAR